WCN26-8040 IMPACT OF TREATMENT WITH NEFECON ON SERUM BIOMARKERS OF GUT-ASSOCIATED LYMPHOID TISSUE FUNCTION IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY FROM THE PHASE 3 NEFIGARD TRIAL

20260 citationsJournal Articlegold Open Access

Authors

Good health and well-being

Published in: Kidney International Reports

Volume 11, Issue 4, pp. 106305-106305

Field-Weighted Citation Impact: 0.00